NATURE

Taiwan invests in genetic resource for health

Nature, Published online: 28 October 2025; doi:10.1038/d41586-025-03447-0 A large biobanking effort captures genetic and health data from half a million

NATURE

How Napoleon’s army met its doom: DNA reveals surprise illnesses had a role

Nature, Published online: 24 October 2025; doi:10.1038/d41586-025-03487-6 Remains of some of the 300,000 soldiers who died on the retreat from

NATURE

Four game-changing immunology tools to watch

A magnified image of a brain organoid with fluorescent labelling of various cell types.Credit: Thomas Hartung, Johns Hopkins University Advanced

NATURE

Is academic research becoming too competitive? Nature examines the data

Success rates for Europe’s leading research grants are declining — some to single percentage points — as a surge in

NATURE

The US and Europe have cut billions in health aid — can anyone fill the gap?

Who will pay for global health? Scientists and policy leaders explored this question when they met this week at the

NATURE

Economics Nobel prize won by researchers who showed how science boosts growth

The 2025 Sveriges Riksbank Prize for Economic Sciences in Memory of Alfred Nobel has been awarded to three researchers who

NATURE

The world’s first plastics treaty is in crisis: can it be salvaged?

Global consumption of plastics is on the rise, but only a small percentage of plastic waste is recycled. Credit: Justin

NATURE

Customizable AI systems that anyone can adapt bring big opportunities — and even bigger risks

In the past three months, several state-of-the-art AI systems have been released with open weights, meaning their core parameters can

NATURE

Weaponizing uncertainty in science and in public health puts people in harm’s way

You have full access to this article via your institution. Head of the US Food and Drugs Administration Marty Makary

NATURE

Evolution of drug-resistant ovarian-cancer clones tracked in patients

RESEARCH BRIEFINGS 01 October 2025 After an initial treatment response, most ovarian cancers recur because of drug-resistant cell populations. Blood-based